China Health Technology Group Holding Co (OTCPK:CHBOF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
China Health Technology Group Holding Co EBITDA Margin % Related Terms
China Health Technology Group Holding Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co EBITDA Margin % Chart
China Health Technology Group Holding Co Annual Data
CHBOF vs SSD, UFPI, BCC: EBITDA Margin % Comparison
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co EBITDA Margin % vs Forest Products Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co (CHBOF) has a EBITDA Margin % of 20.52% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on China Health Technology Group Holding Co and its competitors. According to the industry distribution chart, China Health Technology Group Holding Co ranks #18 out of 283 companies in the Forest Products industry, placing it in the top 6.4%.
Is China Health Technology Group Holding Co's EBITDA Margin % too high?
China Health Technology Group Holding Co's current EBITDA Margin % is 20.52%. The Forest Products industry median EBITDA Margin % is 6.78. China Health Technology Group Holding Co's value of 20.52% is 202.7% above this industry median. Based on the distribution chart, China Health Technology Group Holding Co ranks #18 out of 283 companies in the Forest Products industry, which is in the top quartile — a strong position relative to peers. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's EBITDA Margin % compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #18 out of 283 companies for EBITDA Margin %. This places China Health Technology Group Holding Co in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 6.78. China Health Technology Group Holding Co's value of 20.52% is 202.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Forest Products company?
The median EBITDA Margin % among Forest Products companies is 6.78, based on 283 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current EBITDA Margin % of 20.52% is 202.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on China Health Technology Group Holding Co and its competitors. For the Forest Products industry, the median EBITDA Margin % is 6.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current EBITDA Margin % is 20.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current EBITDA Margin % of 20.52%. The stock's GF Value™ is $0.07, compared to a current price of $0.03 — trading 52.9% below its estimated fair value. The current EBITDA Margin % is 20.52% and 202.7% above the Forest Products industry median of 6.78. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current EBITDA Margin % is 20.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 52.9% below its estimated GF Value™ of $0.07.
Key valuation signals for CHBOF:
EBITDA Margin %: 20.52%
GF Value™: $0.07 vs. price of $0.03 (52.9% below fair value)
Industry Position: 202.7% above the Forest Products median (#18 of 283)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Business Description
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score
Get the complete analysis for CHBOF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
